ClearPoint Neuro Inc. (CLPT)

Market Cap	239.41M
Revenue (ttm)	19.66M
Net Income (ttm)	-16.20M
Shares Out	24.50M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,368
Open	9.69
Previous Close	9.75
Day's Range	9.15 - 9.79
52-Week Range	7 - 16.96
Beta	1.11
Analysts	Buy
Price Target	20.66 (+117.5%)
Earnings Date	Nov 8, 2022

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration a...

• Industry: Health Care Equipment & Supplies
• Founded: 1998
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT

Financial Performance

In 2021, CLPT's revenue was $16.30 million, an increase of 27.05% compared to the previous year's $12.83 million. Losses were -$14.41 million, 112.5% more than in 2020.

Analyst Forecast

According to 8 analysts, the average rating for CLPT stock is "Buy." The 12-month stock price forecast is 20.66, which is an increase of 117.47% from the latest price.

Price Target

$20.66

(117.47% upside)

Analyst Consensus: Buy